SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001422848-15-000015
Filing Date
2015-02-10
Accepted
2015-02-10 12:40:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G edgkite.txt SC 13G 7047
  Complete submission text file 0001422848-15-000015.txt   8534
Mailing Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071 213-486-9200
Capital Research Global Investors (Filed by) CIK: 0001422848 (see all company filings)

IRS No.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G

Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Subject) CIK: 0001510580 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-88615 | Film No.: 15592049
SIC: 2836 Biological Products, (No Diagnostic Substances)